ARCHIVES

NCI Warns Of Pill’s Potential Tumor Threat

This article is from The Cancer Letter archive.

Vol. 02 No. 14 | April 2, 1976

Download PDF Visit The Full Archive

Related Articles

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Community Oncology Program Proves Technology Transfer Can Work; Survival Improvement Shown

March 21, 1980

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

Samuel Waksal Pleads Guilty To Tax Evasion

March 7, 2003